Clinical Trial

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-01; most recent amendment 2026-06-25.
Status change: Enrolling by Invitation → Recruiting 2025-01-08
Trial Details
NCT Number NCT06238765
Lead Sponsor CorEvitas
Conditions Atopic Dermatitis
Enrollment 1,500 participants
Start Date 2023-12-02
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-29